Lexicon Pharmaceuticals
LXRX
LXRX
137 hedge funds and large institutions have $1.59B invested in Lexicon Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 48 increasing their positions, 39 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
5% more funds holding
Funds holding: 131 → 137 (+6)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
137
Holding in Top 10
2
Calls
$13.2M
Puts
$9.32M
Top Buyers
| 1 | +$5.33M | |
| 2 | +$4.35M | |
| 3 | +$3.43M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$2.95M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$2.82M |
Top Sellers
| 1 | -$9.34M | |
| 2 | -$9.07M | |
| 3 | -$4.07M | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
-$3.14M |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$2.36M |